NIA
NIH, Partners Commit $74.9M to New Phase of Alzheimer's Program
AMP AD 2.0 will look to bring precision medicine technologies to Alzheimer's biomarker and target discovery over the next five year.
IsoPlexis Receives $2M SBIR Grant for Alzheimer's Research
The Phase 2 grant is for work the company is doing to analyze the proteomic responses of immune cells in patients with Alzheimer's and related conditions.
Alzheimer's Disease Test Firm DiamiR Awarded Additional $345K From NIA
The blood-based test is designed to detect changes in levels of microRNAs that are enriched in specific brain regions affected by Alzheimer's disease.
Alzheimer's Disease Meta-Analysis Identifies Five New Risk Genes
The findings implicated immune response, lipid metabolism, tau binding proteins, and amyloid precursor protein metabolism pathways in disease risk.
UPenn Reimplements Alzheimer's Disease Data Storage Site, Pushes Downstream Open-Access Research
Premium
The UPenn team will collect genetic information from outside patient cohorts, reorganize it in a streamlined process, and provide a database for downstream studies.
Jul 31, 2014
Genomics in the Journals: Arrays 2014.07.31
Feb 12, 2013